Study reveals breast pain can be only indicator of breast cancer. Findings challenge reluctance to image for breast pain alone.
In the controversy surrounding using breast pain as a reason for diagnostic imaging, researchers find cancers may manifest in the absence of other signs or symptoms. During a study presented Thursday at the RSNA meeting, researchers found eight of 500 women seeking breast exams for breast pain were diagnosed with breast cancer.
Breast pain is one of the most common reasons prompting a breast exam, according to Dr. Lauren Stein, from the University of Michigan, who presented the study. The reported prevalence of breast cancer in women presenting with breast pain ranges from 0% to 7%. But the literature about imaging women with breast pain is limited, hence there is some controversy regarding diagnostic imaging for breast pain.
Stein and colleagues conducted a retrospective study of 500 consecutive women referred to breast imaging for isolated breast pain. All cancer cases were reviewed to establish geographic correlation of the cancer and the site of pain. Cancers diagnosed within six months of imaging were considered acute and those diagnosed more than six months after imaging were considered subsequent.
Of the eight cancers, three were acute and five were subsequent. Diagnostic mammography was a true positive in all acute cases. The incidence of acute cancer was 0.6%; all three patients reported focal breast pain and all three cancers were in the same geographic location as the pain.
Of the subsequent cancers, four were detected by mammographic screening and one had a palpable finding with a positive mammogram.
The eight cancers were invasive ductal carcinoma (five), invasive lobular carcinoma (one), and ductal carcinoma in situ (two).
The sensitivity of two-view mammography for the detection of cancer in patients with pain was 66.7% and the negative predictive value was 99.8%.
The sensitivity of greater than two-view mammography for the detection of cancer in patients with pain was 100% and the negative predictive value was 100%.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.